What is new in CDG?
Abstract
Congenital disorders of glycosylation (CDG) are one group among the disorders of glycosylation. The latter comprise defects associated with hypoglycosylation but also defects with hyperglycosylation. Genetic diseases with hypoglycosylation can be divided in primary congenital disorders of glycosylation (CDG) and in genetic diseases causing secondary hypoglycosylation. This review covers the human CDG highlights from the last 3 years (2014-2016) following a summary of the actual status of CDG. It expands on 23 novel CDG namely defects in SLC39A8, CAD, NANS, PGM3, SSR4, POGLUT1, NUS1, GANAB, PIGY, PIGW, PIGC, PIGG, PGAP1, PGAP3, VPS13B, CCDC115, TMEM199, ATP6AP1, ATP6V1A, ATP6V1E1, TRAPPC11, XYLT1 and XYLT2. Besides, it discusses novel phenotypes of known CDG (DHDDS-CDG, ALG9-CDG, EXT2-CDG, PIGA-CDG, PIGN-CDG), the elucidation of putative glycosyltransferase disorders as O-mannosylglycan synthesis disorders (TMEM5-CDG, ISPD-CDG, FKTN-CDG, FKRP-CDG), a novel CDG mechanism, advances in diagnosis, pathogenesis, treatment and finally an updated list of the 104 known CDG.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CDGs comprise all genetic defects associated with hyper- or hypo-glycosylation.
“CDGs comprise all genetic defects associated with hyper- or hypo-glycosylation [422].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [422]
Cites
Symbol Nomenclature for Graphical Representations of Glycans
Varki, A. P., Cummings, R. D., Aebi, M., Packer, N. H., Seeberger, P. H., Esko, J. D., Stanley, P., Hart, G. W., Darvill, A. G., Kinoshita, T., et al. (2015) · Glycobiology · doi:10.1093/glycob/cwv091 · Cited by 1,060 · see citing works
Porath, B., Gainullin, V. G., Cornec-Le Gall, E., Dillinger, E. K., Heyer, C. M., Hopp, K., Edwards, M. E., Madsen, C. D., Mauritz, S. R., Banks, C. J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.004 · Cited by 475 · see citing works
SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation
Park, J. H., Hogrebe, M., Grüneberg, M., Chesne, I. D., von der Heiden, A., Reunert, J., Schlingmann, K. P., Boycott, K. M., Beaulieu, C. L., Mhanni, A. A., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.11.003 · Cited by 315 · see citing works
Solving Glycosylation Disorders: Fundamental Approaches Reveal Complicated Pathways
Freeze, H. H., Chong, J. X., Bamshad, M. J., & Ng, B. G. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.024 · Cited by 264 · see citing works
Zhang, Y., Yu, X., Ichikawa, M., Lyons, J. J., Datta, S., Lamborn, I. T., Jing, H., Kim, E. S., Biancalana, M., Wolfe, L. A., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.013 · Cited by 247 · see citing works
Neurological Aspects of Human Glycosylation Disorders
Freeze, H. H., Eklund, E. A., Ng, B. G., & Patterson, M. C. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-034019 · Cited by 243 · see citing works
Boycott, K. M., Beaulieu, C. L., Kernohan, K. D., Gebril, O. H., Mhanni, A. A., Chudley, A. E., Redl, D., Qin, W., Hampson, S., Küry, S., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.11.002 · Cited by 238 · see citing works
Kanagawa, M., Kobayashi, K., Tajiri, M., Manya, H., Kuga, A., Yamaguchi, Y., Akasaka‐Manya, K., Furukawa, J., Mizuno, M., Kawakami, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.017 · Cited by 226 · see citing works
Sassi, A., Lazaroski, S., Wu, G., Haslam, S. M., Fliegauf, M., Mellouli, F., Patıroğlu, T., Ünal, E., Özdemir, M. A., Jouhadi, Z., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.025 · Cited by 197 · see citing works
Stray‐Pedersen, A., Backe, P. H., Sorte, H. S., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.05.007 · Cited by 184 · see citing works
CDG nomenclature: Time for a change!
Jaeken, J., Hennet, T., Matthijs, G., & Freeze, H. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.005 · Cited by 172 · see citing works
Self-citationNANS-mediated synthesis of sialic acid is required for brain and skeletal development
van Karnebeek, C. D. M., Bonafé, L., Wen, X.-Y., Tarailo-Graovac, M., Balzano, S., Royer-Bertrand, B., Ashikov, A., Garavelli, L., Mammi, I., Turolla, L., et al. (2016) · Nature Genetics · doi:10.1038/ng.3578 · Cited by 164 · see citing works
Basmanav, F. B., Oprişoreanu, A., Pasternack, S. M., Thiele, H., Fritz, G., Wenzel, J., Größer, L., Wehner, M., Wolf, S., Fagerberg, C. R., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.12.003 · Cited by 154 · see citing works
Jansen, E. J. R., Timal, S., Ryan, M., Ashikov, A., van Scherpenzeel, M., Graham, L. A., Mandel, H., Hoischen, A., Iancu, T. C., Raymond, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11600 · Cited by 149 · see citing works
ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan
Gerin, I., Ury, B., Breloy, I., Bouchet-Séraphin, C., Bolsée, J., Halbout, M., Graff, J., Vertommen, D., Muccioli, G. G., Séta, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11534 · Cited by 145 · see citing works
Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation
Lam, C. T., Ferreira, C. R., Krasnewich, D. M., Toro, C., Latham, L. L., Zein, W. M., Lehky, T., Brewer, C. C., Baker, E. H., Thurm, A. E., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.75 · Cited by 142 · see citing works
Park, E. J., Grabińska, K. A., Guan, Z., Stránecký, V., Hartmannová, H., Hodaňová, K., Barešová, V., Sovová, J., József, L., Ondrušková, N., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.016 · Cited by 139 · see citing works
Mosaicism of the UDP-Galactose Transporter SLC35A2 Causes a Congenital Disorder of Glycosylation
Ng, B. G., Buckingham, K. J., Raymond, K., Kircher, M., Turner, E. H., He, M., Smith, J. D., Eroshkin, A. M., Szybowska, M., Losfeld, M. E., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.03.012 · Cited by 132 · see citing works
CADmutations and uridine-responsive epileptic encephalopathy
Koch, J., Mayr, J. A., Alhaddad, B., Rauscher, C., Bierau, J., Kovács-Nagy, R., Coene, K. L. M., Bader, I., Holzhacker, M., Prokisch, H., et al. (2016) · Brain · doi:10.1093/brain/aww300 · Cited by 128 · see citing works
Congenital disorders of glycosylation: new defects and still counting
Scott, K. M., Gadomski, T., Kozicz, T., et al. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9720-9 · Cited by 125 · see citing works
Bögershausen, N., Shahrzad, N., Chong, J. X., von Kleist-Retzow, J., Stanga, D., Li, Y., Bernier, F. P., Loucks, C. M., Wirth, R., Puffenberger, E. G., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.028 · Cited by 118 · see citing works
Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction
Hennet, T., & Cabalzar, J. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.03.002 · Cited by 117 · see citing works
Praissman, J. L., Willer, T., Sheikh, M. O., et al. (2016) · eLife · doi:10.7554/elife.14473 · Cited by 117 · see citing works
Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa
Damme, T. V., Gardeitchik, T., Mohamed, M., Guerrero‐Castillo, S., Freisinger, P., Guillemyn, B., Kariminejad, A., Dalloyaux, D., van Kraaij, S. A. W., Lefeber, D. J., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.12.010 · Cited by 114 · see citing works
Kodera, H., Nakamura, K., Osaka, H., Maegaki, Y., Haginoya, K., Mizumoto, S., Kato, M., Okamoto, N., Iai, M., Kondo, Y., et al. (2013) · Human Mutation · doi:10.1002/humu.22446 · Cited by 111 · see citing works
Chiyonobu, T., Inoue, N., Morimoto, M., Kinoshita, T., & Murakami, Y. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102156 · Cited by 108 · see citing works
A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss
Servián‐Morilla, E., Takeuchi, H., Lee, T. V., Clarimón, J., Mavillard, F., Área-Gómez, E., Rivas, E., Nieto-González, J. L., Rivero, M., Cabrera‐Serrano, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505815 · Cited by 108 · see citing works
Morava, É. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.06.002 · Cited by 101 · see citing works
Cohen syndrome is associated with major glycosylation defects
Duplomb, L., Duvet, S., Picot, D., Jégo, G., Chehadeh, S. E., Marle, N., Gigot, N., Aral, B., Carmignac, V., Thévenon, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt630 · Cited by 100 · see citing works
CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation
Jansen, J. C., Çırak, S., van Scherpenzeel, M., Timal, S., Reunert, J., Rust, S., Pérez, B., Vicogne, D., Krawitz, P. M., Wada, Y., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.010 · Cited by 99 · see citing works
Self-citationJansen, J. C., Timal, S., van Scherpenzeel, M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.011 · Cited by 91 · see citing works
Dörre, K., Olczak, M., Wada, Y., Sosicka, P., Grüneberg, M., Reunert, J., Kurlemann, G., Fiedler, B., Biskup, S., Hörtnagel, K., et al. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9828-6 · Cited by 88 · see citing works
Ng, B. G., Wolfe, L. A., Ichikawa, M., Markello, T. C., He, M., Tifft, C. J., Gahl, W. A., & Freeze, H. H. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv057 · Cited by 86 · see citing works
Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia
Makrythanasis, P., Kato, M., Zaki, M. S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.02.007 · Cited by 86 · see citing works
The genotypic and phenotypic spectrum of PIGA deficiency
Tarailo‐Graovac, M., Sinclair, G. B., Stöckler‐Ipsiroglu, S., Allen, M. I. V., Rozmus, J., Shyr, C., Biancheri, R., Oh, T., Sayson, B., Lafek, M., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0243-8 · Cited by 85 · see citing works
Manya, H., Yamaguchi, Y., Kanagawa, M., Kobayashi, K., Tajiri, M., Akasaka‐Manya, K., Kawakami, H., Mizuno, M., Wada, Y., Toda, T., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751917 · Cited by 83 · see citing works
Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation
Riemersma, M., Froese, D. S., van Tol, W., Engelke, U. F. H., Kopec, J., van Scherpenzeel, M., Ashikov, A., Krojer, T. J., von Delft, F., Tessari, M., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.10.014 · Cited by 82 · see citing works
Congenital Disorders of Glycosylation with Emphasis on Cerebellar Involvement
Barone, R. M. E., Fiumara, A., & Jaeken, J. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1387197 · Cited by 80 · see citing works
Self-citationClinical diagnostics and therapy monitoring in the congenital disorders of glycosylation
van Scherpenzeel, M., Willems, E., & Lefeber, D. J. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-015-9639-x · Cited by 80 · see citing works
Mutations inPIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies
Ilkovski, B., Pagnamenta, A. T., O’Grady, G. L., Kinoshita, T., Howard, M. F., Lek, M., Thomas, B., Turner, A., Christodoulou, J., Sillence, D. O., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv331 · Cited by 72 · see citing works
Defects in the COG complex and COG-related trafficking regulators affect neuronal Golgi function
Climer, L. K., Dobretsov, M. G., & Lupashin, V. V. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00405 · Cited by 71 · see citing works
Immunological aspects of congenital disorders of glycosylation (CDG): a review
Monticelli, M., Ferro, T., Jaeken, J., Ferreira, V. D. R., & Videira, P. A. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9954-9 · Cited by 69 · see citing works
Self-citationLosfeld, M., Ng, B. G., Kircher, M., Buckingham, K. J., Turner, E. H., Eroshkin, A. M., Smith, J. D., Shendure, J., Nickerson, D. A., Bamshad, M. J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt550 · Cited by 68 · see citing works
Zhang, W., James, P. M., Ng, B. G., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.243279 · Cited by 68 · see citing works
Gain-of-glycosylation mutations
Vogt, G., Vogt, B., Chuzhanova, N., Julenius, K., Cooper, D. N., & Casanova, J.-L. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.008 · Cited by 67 · see citing works
Liang, W., Zhu, W., Mitsuhashi, S., et al. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0056-4 · Cited by 63 · see citing works
de la Morena‐Barrio, M. E., Martínez‐Martínez, I., de Cos, C., Wypasek, E., Roldán, V., Undas, A., van Scherpenzeel, M., Lefeber, D. J., Toderici, M., Sevivas, T. S., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13372 · Cited by 59 · see citing works
Self-citationSabry, S., Vuillaumier‐Barrot, S., Mintet, E., Fasseu, M., Valayannopoulos, V., Héron, D., Dorison, N., Mignot, C., Séta, N., Chantret, I., et al. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0468-1 · Cited by 59 · see citing works
Rymen, D., & Jaeken, J. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9678-7 · Cited by 56 · see citing works
Self-citationKoehler, K., Milev, M. P., Prematilake, K., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104108 · Cited by 55 · see citing works
Argov, Z., Caraco, Y., Lau, H., Pestronk, A., Shieh, P. B., Skrinar, A. M., Koutsoukos, T., Ahmed, R., Martinisi, J., & Kakkis, E. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-159900 · Cited by 53 · see citing works
Spondyloocular Syndrome: Novel Mutations in XYLT2 Gene and Expansion of the Phenotypic Spectrum
Taylan, F., Costantini, A., Coles, N., Pekkinen, M., Héon, E., Şıklar, Z., Berberoğlu, M., Kämpe, A. J., Kıykım, E., Grigelioniené, G., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2834 · Cited by 53 · see citing works
Fryns Syndrome Associated with Recessive Mutations in PIGN in two Separate Families
McInerney-Leo, A. M., Harris, J. E., Gattas, M. R., et al. (2016) · Human Mutation · doi:10.1002/humu.22994 · Cited by 50 · see citing works
Morava, É., Tiemes, V., Thiel, C., et al. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9945-x · Cited by 48 · see citing works
Edvardson, S., Murakami, Y., Nguyen, T. T. M., Shahrour, M., St-Denis, A., Shaag, A., Damseh, N., Le Deist, F., Bryceson, Y., Abu-Libdeh, B., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104202 · Cited by 47 · see citing works
Knaus, A., Awaya, T., Helbig, I., et al. (2016) · Human Mutation · doi:10.1002/humu.23006 · Cited by 45 · see citing works
Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation
Matalonga, L., Bravo, M., Serra‐Peinado, C., et al. (2016) · Human Mutation · doi:10.1002/humu.23145 · Cited by 44 · see citing works
Genetic defects in the hexosamine and sialic acid biosynthesis pathway
Willems, A. P., van Engelen, B. G. M., & Lefeber, D. J. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.12.017 · Cited by 43 · see citing works
Genetic defects in dolichol metabolism
Buczkowska, A., Świeżewska, E., & Lefeber, D. J. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9760-1 · Cited by 42 · see citing works
A recurrent germline mutation in the PIGA gene causes Simpson‐Golabi‐Behmel syndrome type 2
Fauth, C., Steindl, K., Toutain, A., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37452 · Cited by 41 · see citing works
ALG8-CDG: novel patients and review of the literature
Höck, M., Wegleiter, K., Ralser, E., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0289-7 · Cited by 40 · see citing works
Tham, E., Eklund, E. A., Hammarsjö, A., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.91 · Cited by 40 · see citing works
Expanding the Molecular and Clinical Phenotype of SSR4-CDG
Ng, B. G., Raymond, K., Kircher, M., et al. (2015) · Human Mutation · doi:10.1002/humu.22856 · Cited by 36 · see citing works
Lundin, K. E., Hamasy, A., Backe, P. H., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.10.002 · Cited by 35 · see citing works
Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2
Guo, L. Z., Elcioglu, N. H., Iida, A., et al. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.143 · Cited by 34 · see citing works
Smith‐Packard, B., Myers, S. M., & Williams, M. S. (2015) · JIMD Reports · doi:10.1007/8904_2015_416 · Cited by 32 · see citing works
Kimizu, T., Takahashi, Y., Oboshi, T., et al. (2016) · Brain and Development · doi:10.1016/j.braindev.2016.09.009 · Cited by 30 · see citing works
Serum transferrin carrying the xeno‐tetrasaccharide NeuAc‐Gal‐GlcNAc2 is a biomarker of ALG1‐CDG
Bengtson, P., Ng, B. G., Jaeken, J., et al. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9884-y · Cited by 29 · see citing works
Self-citationFarhan, S. M. K., Wang, J., Robinson, J. F., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103279 · Cited by 29 · see citing works
Wada, Y. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-015-9636-0 · Cited by 26 · see citing works
A novel mutation in PIGW causes glycosylphosphatidylinositol deficiency without hyperphosphatasia
Hogrebe, M., Murakami, Y., Wild, M. K., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37950 · Cited by 26 · see citing works
Kettwig, M., Elpeleg, O. N., Wegener, E., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0602-7 · Cited by 25 · see citing works
Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23APreprint
Gupta, S., Fahiminiya, S., Wang, T. S., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a000737 · Cited by 22 · see citing works
Further Delineation of the ALG9-CDG Phenotype
Alsubhi, S., Alhashem, A. M., Alazami, A. M., et al. (2015) · JIMD Reports · doi:10.1007/8904_2015_504 · Cited by 20 · see citing works
Silveira, C., Leal, G. F., & Cavalcanti, D. P. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37858 · Cited by 20 · see citing works
Lee, J., Kim, H., Park, Y., et al. (2017) · Ophthalmic Genetics · doi:10.1080/13816810.2016.1232415 · Cited by 19 · see citing works
RFT1‐congenital disorder of glycosylation (CDG) syndrome: a cause of early‐onset severe epilepsy
Aeby, A., Prigogine, C., Vilain, C. N., et al. (2016) · Epileptic Disorders · doi:10.1684/epd.2016.0802 · Cited by 17 · see citing works
Krasnewich, D. M. (2014) · Cancer Biomarkers · doi:10.3233/cbm-130374 · Cited by 13 · see citing works
Kouwenberg, D., Gardeitchik, T., Mohamed, M., et al. (2013) · Pediatric Dermatology · doi:10.1111/pde.12233 · Cited by 12 · see citing works
Congenital Disorders of Glycosylation, Dolichol and Glycosylphosphatidylinositol Metabolism
Jaeken, J., & Morava, É. (2016) · Springer eBooks · doi:10.1007/978-3-662-49771-5_41 · Cited by 11 · see citing works
Self-citationNormal glycosylation screening does not rule out SRD5A3-CDG
Mohamed, M., Cantagrel, V., Al‐Gazali, L., Wevers, R. A., Lefeber, D. J., & Morava, É. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.260 · Cited by 9 · see citing works
Morava, É., Tiemes, V., Thiel, C., et al. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9967-4 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Artificial intelligence (AI) in rare diseases: is the future brighter?
Brasil, S., Pascoal, C., Francisco, R., dos Reis Ferreira, V., A. Videira, P., & Valadão, G. (2019) · Genes · doi:10.3390/genes10120978 · Cited by 160 · see citing works
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20 · see citing works
“ciated with hyper- or hypo-glycosylation [422].”
- Authors
- Jaeken, J., & Péanne, R.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Jaeken, Jaak
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2017-05-08
- Volume
- 40
- Issue
- 4
- Pages
- 569-586
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2613615193
- Cited by
- 170
- References
- 82
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 14 · 2022: 16 · 2021: 29 · 2020: 23 · 2019: 26 · 2018: 25 · 2017: 6
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-06-26)
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek (G.0553.08 and G.0505.12)
- Horizon 2020 (643578)
- Topics
- Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Keywords
- congenital disorders of glycosylation, hypoglycosylation, hyperglycosylation, SLC39A8, PGM3
- MeSH terms
- Genotype, Glycosylation, Golgi Apparatus, Humans, Liver, Mutation, Phenotype, Biomarkers, Congenital Disorders of Glycosylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review